A series of reports has revealed that adenosine has a plethora of biological actions toward a large variety of cells. In this study, we investigated the influence of adenosine receptor activation on iNOS mRNA expression in human gingival epithelial cells (HGEC) and SV-40-transformed HGEC. HGEC expressed adenosine receptor subtypes A1, A2a, and A2b, but not A3 mRNA. Ligation of adenosine receptors by a receptor agonist, 2-chloroadenosine (2CADO), enhanced iNOS mRNA expression by both HGEC and transformed HGEC. In addition, the adenosine receptor agonist enhanced the production of NO2-/NO3-, NO-derived stable end-products. An enhanced expression of iNOS mRNA and NO2-/NO3- was also observed when SV40-transformed HGEC were stimulated with CPA or CGS21680, A1- or A2a-selective adenosine receptor agonists, respectively. These results provide new evidence for the possible involvement of adenosine in the regulation of inflammatory responses by HGEC in periodontal tissues.
Get full access to this article
View all access options for this article.
References
1.
Beg AA, Finco TS, Nantermet PV, Baldwin AS -1993-. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IkB-α: a mechanism for NF-κB activation. Mol Cell Biol13:3301–3310.
2.
Chartrain NA, Geller DA, Koty PP, Sitrin NF, Nussler AK, Hoffman EP, et al. -1994-. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem269:6765–6772.
3.
Cronstein BN, Eberle MA, Gruber HE, Levin RI -1991-. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA88:2441–2445.
4.
Cronstein BN, Naime D, Ostad E -1993-. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest92:2675–2682.
5.
Hasko G, Szabo C, Nemeth ZH, Kvetan V, Pastores SM, Vizi ES -1996-. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol157:4634–4640.
6.
Ikeda U, Kurosaki K, Shimpo M, Okada K, Saito T, Shimada K -1997-. Adenosine stimulates nitric oxide synthesis in rat cardiac myocytes. Am J Physiol273:H59–65.
7.
Janoff EN, Hayakawa H, Taylor DN, Fasching CE, Kenner JR, Jaimes E, et al. -1997-. Nitric oxide production during Vibrio cholerae infection. Am J Physiol273:1160–1167.
8.
Kendall HK, Haase HR, Li H, Xiao YG, Bartold PM -2000-. Nitric oxide synthase type-II is synthesized by human gingival tissue and cultured human gingival fibroblasts. J Periodontal Res35:194–200.
9.
Li JM, Fenton RA, Cutler BS, Dobson JG Jr -1995-. Adenosine enhances nitric oxide production by vascular endothelial cells. Am J Physiol269-C-:519–523.
10.
MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, et al. -1995-. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell81:641–650.
11.
Moilanen E, Vapaatalo H -1995-. Nitric oxide in inflammation and immune response. Ann Med27:359–367.
12.
Murakami S, Shimabukuro Y, Miki Y, Saho T, Hino E, Kasai D, et al. -1994-. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis. J Immunol152:467–477.
13.
Murakami S, Terakura M, Kamatani T, Hashikawa T, Saho T, Shimabukuro Y, et al. -2000-. Adenosine regulates the production of interleukin-6 by human gingival fibroblasts via cyclic AMP/protein kinase A pathway. J Periodontal Res35:93–101.
14.
Murakami S, Hashikawa T, Saho T, Takedachi M, Nozaki T, Shimabukuro Y, et al. -2001-. Adenosine regulates the IL-1β-induced cellular functions of human gingival fibroblasts. Int Immunol13:1533–1540.
15.
Nathan C -1992-. Nitric oxide as a secretory product of mammalian cells. FASEB J6:3051–3064.
16.
Nathan CF, Hibbs JB -1991-. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol3:65–70.
17.
Palmer RM, Rees DD, Ashton DS, Moncada S -1988-. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun153:1251–1256.
18.
Pedata F, Corsi C, Melani A, Bordoni F, Latini S -2001-. Adenosine extracellular brain concentrations and role of A2A receptors in ischemia. Ann NY Acad Sci939:74–84.
19.
Prasad KN, Edwards Prasad J, Carvalho E, La Rosa FG, Balbinder E, Meyers A, et al. -1992-. Establishment of primary cultures of rat and human parotid epithelial cells for transfection experiments. In Vitro Cell Dev Biol28-A-:493–499.
20.
Resta R. Yamashita Y, Thompson LR -1998-. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev161:95–109.
21.
Salzman AL, Eaves Pyles T, Linn SC, Denenberg AG, Szabo C -1998-. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology114:93–102.
22.
Shibuki K, Okada D -1991-. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature349:326–328.
23.
Strohmeier GR, Lencer WI, Patapoff TW, Thompson LF, Carlson SL, Moe SJ, et al. -1997-. Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia. J Clin Invest99:2588–2601.
24.
Sunahara RK, Dessauer CW, Gilman AG -1996-. Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol36:461–468.
25.
Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, et al. -1995-. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature375:408–411.
